A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC

SOCRATES HCC will investigate whether a radiotherapy technique (called SABR) can treat early stage liver cancer more effectively than current treatments which use heating probes directly inserted into the tumour or chemotherapy or radioactive particles injected into the blood supply of the tumour.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australasian Gastro-Intestinal Trials Group (AGITG), Abdominal Radiology Group of Australia and New Zealand (ARGANZ) & Gastrointestinal Society of Australia (GESA)

Participating Centres

Accrual Target

218

Current Accrual

Trial Chairperson

Prof Alan Wigg, Flinders Medical Centre, SA, Australia
A/Prof David Pryor, Princess Alexandra Hospital, QLD, Australia

Trial Contact

SOCRATES_HCC@trog.com.au

Clinical Trial Registration

Related Post

Prof Wee Loon Ong
24 September, 2025

Prostate Cancer Month: Focus on the TROG Genitourinary Working Party

To mark Prostate Cancer Month in September, we asked

24 September, 2025

TROG members and staff celebrate World Radiotherapy Awareness Day

LATEST NEWS: 24 September 2025 TROG Cancer Research staff